What is the Current Share Price of Shukra Pharmaceuticals Ltd?
- Answer Field
-
Shukra Pharmaceuticals Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 40.13 as on Mar 20 2026 03:30 PM.
As of the latest trading session, Shukra Pharmaceuticals share price is currently at ₹37.5, which is down by ₹-1.81 from its previous closing. Today, the stock has fluctuated between ₹37.35 and ₹40.82. Over the past year, Shukra Pharmaceuticals has achieved a return of 62.14%. In the last month alone, the return has been -3.44%.
| Particulars | DEC 2025 (Values in Cr) |
|---|---|
| Revenue | 39.13 |
| Operating Expense | 13.12 |
| Net Profit | 20.36 |
| Net Profit Margin (%) | 52.03 |
| Earnings Per Share (EPS) | 0.47 |
| EBITDA | 27.95 |
| Effective Tax Rate (%) | 24.11 |
| Company Name | Price | P/E | P/B | Market Cap | 52 Week Low | 52 Week High |
|---|---|---|---|---|---|---|
| AMBALAL SARABHAI ENTERPRISES L | 28.41 | 12.30 | 1.47 | 217.72 | 23.12 | 42.00 |
| BLISS GVS PHARMA LTD | 201.65 | 19.28 | 1.88 | 2133.23 | 105.05 | 244.05 |
| CIPLA LTD | 1298.80 | 22.07 | 3.18 | 104914.55 | 1283.00 | 1672.20 |
| FERMENTA BIOTECH LIMITED | 339.00 | 11.28 | 2.55 | 997.71 | 241.30 | 399.00 |
| Company Name | Price | P/E | P/B | Market Cap | 52 Week Low | 52 Week High |
|---|---|---|---|---|---|---|
| AMBALAL SARABHAI ENTERPRISES L | 28.41 | 27.32 | 3.96 | 217.72 | 23.12 | 42.00 |
| AMRUTANJAN HEALTH CARE LTD. | 528.05 | 26.40 | 4.46 | 1526.63 | 522.15 | 789.95 |
| ASTRAZENECA PHARMA INDIA LTD. | 8358.20 | 100.45 | 26.15 | 20895.50 | 6501.60 | 10653.05 |
| BLISS GVS PHARMA LTD | 201.65 | 27.47 | 1.93 | 2133.23 | 105.05 | 244.05 |
Choose a Plan That Suits Your Goals and Needs
Freedom Pack
Subscription Charge : FREE
Professional Pack
Subscription Fee : ₹2,500 Yearly
Signature
Account Opening : FREE
*Note: The Freedom Pack is free for the first year and has an annual fee of ₹431 from the second year onwards.
Shukra Pharmaceuticals Limited, formerly known Relish Pharmaceuticals Limited was established in March, 1993 and later on the Company name was changed from Relish Pharmaceuticals Limited to Shukra Pharmaceuticals Limited effective on September 22, 2016. The Company is presently engaged in the business of manufacturing and trading of pharmaceuticals formulations and laboratory testing.
The company provides varieties of products to the clientele. Their product portfolio includes Antibiotics (Penicillin), Anti Biotics (Cephalosporin), Anti Biotics, Macrolides, Quinolones, Anti Bacterial, Anti Fungal, Anti Malarial, Anti Viral, Anti Protozoal, Anti Anthelmintic, Sedative and Tranquilliser, Anti Depressant, Anti Manic, Anti Emetic, Anti Ulcer, Beta Blockers, Diuretics, Analgesic, Analgesic (NASID), Muscle Relaxants, Anti Tuberculosis, Vitamin Products, Anti Allergics, Corticosteroids, Hyper and Hypoglycemic, Others.
The company has four manufacturing divisions namely tablets (General and Beta Lactum) Capsules (General and Beta Lactum), Liquid and small volume parental. Their manufacturing unit is located at Rakanpur in Gujarat.
The company customers include leading Manufacturers like Cadila Healthcare Limited (Zydus), Intas Pharmaceuticals Limited, Cadila Pharmaceuticals Limited, Makers Laboratories Limited, Agenta Pharma Limited etc.
The company has assisted in the development and manufacture of a wide variety of drugs and dosage forms and potency variations for many prestigious pharmaceuticals companies around the world.
In FY 2013-14, the Company got approval from Hon'ble High Court of Gujarat for revival of Relish Pharmaceuticals Limited and Amalgamation of Proper Dealcomm Private Limited with the erstwhile Relish Pharmaceuticals Limited and Re-organization of Share Capital of Relish Pharmaceuticals Limited through the Scheme of Arrangement vide Hon'ble High Court of Gujarat order dated 20 December, 2013.
The Company has achieved WHO-GMP certification, successfully securing a partnership with Meril Healthcare for robotic surgery projects in October 2025.
Shukra Pharmaceuticals Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 40.13 as on Mar 20 2026 03:30 PM.
The market cap of Shukra Pharmaceuticals Ltd for NSE ₹ 0.00 & for BSE ₹ 1,757.20 as on Mar 20 2026 03:30 PM.
The 52 Week High and Low of Shukra Pharmaceuticals Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 65.26 and ₹ 11.74.
The 1 year returns on the stock has been 62.14%.
As on Mar 20 2026 03:30 PM the price-to-earnings (PE) ratio for Shukra Pharmaceuticals Ltd share is 60.67.
As on Mar 20 2026 03:30 PM, the price-to-book (PB) ratio for Shukra Pharmaceuticals Ltd share is 1.50.
You can trade in Shukra Pharmaceuticals Ltd shares with Bajaj Broking by opening a demat account.
To buy Shukra Pharmaceuticals Ltd shares on the Bajaj Broking app, follow these steps:
• Login to the Bajaj Broking App
• Click on the Search Icon
• Search “Shukra Pharmaceuticals Ltd”
• Click on the BUY icon
• Place a buy order specifying the desired quantity of shares.
• Click BUY again to complete the purchase
No results found